Hospira wins French biosimilar drug tender at 45 percent discount
 

Hospira wins French biosimilar drug tender at 45 percent discount
PARIS (Reuters) - A major French hospital group has chosen a cheap copycat version of a top-selling drug for treating its patients with rheumatoid arthritis and Crohn's disease in a victory for a new type of medicine k**wn as biosimilars.***
http://i0.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...BQ:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...BQ:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/Pl6oPwMn20s